Fount of Information

LifeSensors社 SARS-CoV-2 Research Tools: Antigens, Antibodies, Detection Kits

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_1.jpg

Jump Start Your SARS-CoV-2 Research

From antigens and antibodies to detection kits, LifeSensors has tools to assist researchers in studying SARS-CoV-2, and we are happy to discuss customizable services and assays as well!

For enquiries, please click the 'Contact Us' button. To learn about our SARS-CoV research tool line, Click here to see our full line of products.

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_2.png

SARS-CoV-2 Nucleocapsid (N) Protein

The SARS-CoV-2 genome encodes several structural proteins including the nucleocapsid protein (Nucleoprotein; Protein N), which plays a role in virion assembly through its interaction with the viral genome
and the membrane protein. This key protein packages the positive strand viral RNA into a helical ribonucleocapsid. 

SARS-CoV-2 RBD Protein

The N-terminal part of the Spike protein (S1, residues 1-685) initiates the infection process by attaching the virus to host receptors (ACE2, CLEC4M/DC-SIGNR) located on the cell membrane. This interaction, which leads to the internalization of the virus into endosomes is mediated by a stretch of amino acids (residues 319-545) named the receptor binding domain (RBD). The S Protein RBD represents a valuable tool for drug discovery programs targeting SARS-CoV-2 infection.

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_3.png
SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_4.png

SARS-CoV-2 Spike 1 (S1) Protein

The N-terminal part of the Spike protein (S1, residues
1-685) initiates the infection process by attaching the virus to host receptors (ACE2, CLEC4M/DC-SIGNR) located on the cell membrane. This interaction leads to
the internalization of the virus into endosomes). The Spike protein S1 represents a valuable tool for drug discovery programs targeting SARS-CoV-2 infection.

SARS-CoV-2 Spike 2 (S2) Protein

The SARS-CoV-2 genome encodes several non-structural proteins including the Spike glycoprotein (S glycoprotein), which plays a crucial role in the infection of the host. The C-terminal part of the Spike
protein (S2, residues 686-1273) mediates the fusion of the virion and cellular membranes by acting as a class I viral fusion protein. The Spike protein S2 represents a valuable tool for drug discovery programs targeting SARS-CoV-2 infection.

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_5.png
SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_6.jpg

SARS-CoV-2 Nucleocapsid Antibody

The SARS Nucleocapsid Protein Antibody recognizes and binds to both SARS-CoV and SARS-CoV-2 nucleocapsid proteins. The nucleocapsid is a highly conserved and immunogenic viral protein thus representing a valuable tool for diagnostic and vaccine production purposes.

SARS-CoV-2 3CL Protease Antibody

The SARS 3CL-PRO Protein Antibody recognizes and binds to both SARS-CoV and SARS-CoV-2 3CL-PRO enzymes. Since the genome sequence of SARS-CoV-2 is very similar to that of SARS-CoV, inhibition of 3CL-PRO activity represents a viable strategy at the basis of a COVID-19 therapy.

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_7.png
SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_8.png

COVID-19 Nucleocapsid ELISA Research Kit

The COVID-19 Nucleocapsid ELISA Assay is a detection
tool for SARS-CoV-2. This high-throughput method is based on the use of a capture antibody for trapping SARS-CoV-2 nucleocapsid protein on the plate followed by the use of a detection antibody to generate a colorimetric signal. Both the generated signal and the standard calibration curve allow for the absolute quantification of natural or recombinant nucleocapsid protein.

COVID-19 IgG ELISA Research Kit

The COVID-19 IgG ELISA Research Assay is a detection assay for SARS-CoV-2 IgG antibodies. This high-throughput method is based on the use of SARS-CoV-2 nucleocapsid for trapping antibodies on the plate followed by the use of a specific detection antibody for human IgG to generate a colorimetric signal. The generated signal allows for assessing the immune response to SARS-CoV-2 in samples from human origin.

SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_9.png
SARS-CoV-2_Research_Tools_Antigens,_Antibodies,_Detection_Kits_10.png

COVID-19 IgG/IgM/IgA ELISA Research Kit

The COVID-19 IgG/IgM/IgA Total antibody ELISA Research Kit is a detection assay for SARS-CoV-2 antibodies. This high-throughput method is based on the use of SARS-CoV-2 nucleocapsid protein. The N -protein traps antibodies on the plate which allows high level detection. A mixture of detection antibodies towards human IgG, IgM and IgA of SARS-CoV-2 creates a
colorimetric signal. The generated signal assesses the immune response to SARS-CoV-2 in samples from human origin.

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。